Endo Pharmaceuticals Holdings Earnings: Here’s Why Investors are Ambivalent Now
Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP) delivered a profit and met Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company.
Endo Pharmaceuticals Holdings Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 25.29% to $1.09 in the quarter versus EPS of $0.87 in the year-earlier quarter.
Revenue: Rose 2.59% to $708.5 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Endo Pharmaceuticals Holdings Inc. reported adjusted EPS income of $1.09 per share. By that measure, the company missed the mean analyst estimate of $1.09. It missed the average revenue estimate of $739.99 million.
Quoting Management: “2013 is a year of transition for Endo as we begin to manage the entry of generic competition for LIDODERM® and navigate through the headwinds that we have faced recently, including those with OPANA® ER. I continue to be very optimistic about the future of Endo,” said Rajiv De Silva, president and CEO of Endo. “Since joining the company I have focused on assessing our current strategy and operations with a view to identifying our best opportunities for growth and improving profitability. I look forward to sharing these plans in the months ahead.”
Key Stats (on next page)…
Revenue decreased 11.55% from $801.06 million in the previous quarter. EPS decreased 32.72% from $1.62 in the previous quarter.
Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $1.23 to a profit $1.21. For the current year, the average estimate has moved down from a profit of $4.53 to a profit of $4.5 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)